Moderna's Covid-19 Vaccine Recommended for Children Under 6 Years in EU
October 19 2022 - 1:37PM
Dow Jones News
By Sabela Ojea
Moderna Inc. on Wednesday said that its Covid-19 vaccine has
been recommended for marketing authorization in the European Union
to include children under 6 years old.
The biotechnology company said the European Medicines Agency's
Committee for Medicinal Products for Human Use recommended
marketing authorization for a double dose of Moderna's Spikevax
vaccine in children aged six months to 5 years old.
Preliminary efficacy analysis on PCR-confirmed Covid-19 cases
during the Omicron wave showed a two-dose series of Spikevax has
similar levels of efficacy in adults and children under five years
old, Moderna said.
Earlier Wednesday, Pfizer Inc. and BioNTech SE said they
received EU marketing authorization for a Covid-19 vaccine as a
three-dose series for children under 5 years old.
Moderna Chief Executive Officer Stephane Bancel said this new EU
recommendation reaffirms the effectiveness and safety of
Spikevax.
"This recommendation provides parents across Europe with another
option to protect their young children against Covid-19, a group at
high risk of infection and where additional health prevention
measures may not always be feasible," Mr. Bancel said.
Write to Sabela Ojea at sabela.ojea@wsj.com
(END) Dow Jones Newswires
October 19, 2022 13:22 ET (17:22 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
BioNTech (NASDAQ:BNTX)
Historical Stock Chart
From Aug 2024 to Sep 2024
BioNTech (NASDAQ:BNTX)
Historical Stock Chart
From Sep 2023 to Sep 2024